People can get just as emotionally attached to horses as they are to their dogs or cats.
New research shows that horses can be just as meaningful objects of affection for humans as other pets or close human beings. The way people get attached to their horse can now also be reliably assessed through a survey. The bond between humans and horses dates back thousands of years, and horses occupy a unique position in human life, falling somewhere between working animals and companion animals.
How animals get their spots, and why they are beautifully imperfect
In a new study, CU Boulder scientists refined their previous theory of how animal patterns form and successfully recreated imperfections in natural designs, like irregular spots on a leopard. The new mechanism, described October 27 in Matter, could lead to materials that can respond to their environment, such as fabrics that change color on demand for camouflage.
Hyperfibrinolysis in Cats: Insights from a Retrospective Case-Control Study
Hyperfibrinolysis (HFL), a condition characterized by accelerated breakdown of blood clots, has been described in dogs and humans, but data in cats remain limited. A recent retrospective case-control study published in the Journal of Veterinary Internal Medicine sought to identify risk factors associated with HFL in cats and determine whether its presence affects survival.
Why the rise of ‘fur baby’ culture is fuelling overtreatment and major animal welfare issues
An increasingly-concerned group of veterinarians has issued a stark warning about the rise of what they call ‘fur baby culture’, suggesting the anthropomorphising of animals is behind alarming animal welfare problems.
Current Practices in Diagnosing and Managing Canine Cognitive Dysfunction Syndrome
A comprehensive survey of 318 U.S. veterinarians has revealed that while nearly all of us have diagnosed CCDS at some point in our careers, significant gaps remain in our confidence, knowledge, and consensus about best practices.
Veterinary cardiologist, Dr. Hayley McDonald Explains All about Felicyn CA-1
Felycin®-CA1 (sirolimus delayed-release tablets) is the first disease-modifying drug that can give hope to owners of cats with subclinical hypertrophic cardiomyopathy (HCM).Felycin®-CA1 is the first and only FDA conditionally approved once-weekly drug for the management of ventricular hypertrophy in cats with subclinical HCM.